Partnering with
Cancer Research UK Cambridge Centre
Cambridge Enterprise
Founders at Cambridge

Open-ended hypothesis discovery at a scale human teams cannot reach.

Cambridge, UK

Scroll to explore

The Problem

The highest-stakes decisions in medicine are made blind

Drug development fails not from lack of data, but from poor hypothesis selection.

The combinatorial space of targets, biomarkers, and patient strategies is too vast to explore manually. The most promising hypotheses stay invisible.

Existing tools answer questions. They do not decide which questions matter.

0%+
of trial failures tied to patient selection
0%
of drugs fail before reaching patients
$0M+
wasted per Phase III failure
0s
of potential biomarker combinations per indication
Months
for human teams to evaluate one hypothesis
0
tools deciding which hypotheses matter

Our Platform

Open-ended hypothesis hunting

Nethaira deploys networks of AI scientists that don't wait for instructions.

They autonomously explore multimodal biological data, continuously generating, testing, and refining hypotheses to uncover the targets and biomarkers that guide precision trial design.

Not just the ones you thought to ask about. At a scale no human team can match.

From Chaos to Clarity

Data

Network

Hunt

Decide

Spatial Biology Focus

Spatial Omics · NSCLC Tissue
1,800 cells resolved
7 cell phenotypes
MERFISH · 10um res
Scroll to zoom
Drag to pan
Shift+drag rotate

Team

Built by scientists, for scientists

Our team combines deep scientific expertise
with world-class engineering.

 

Advised by leading Cambridge labs.

Contact

Partner with us

We are selecting strategic partners for early access. Translational teams working on spatial biology, patient stratification, or biomarker discovery.

contact@nethaira.com
Cambridge, United Kingdom